Trials / Completed
CompletedNCT00338052
Study of Bleeding With Extended Administration of an Oral Contraceptive
Open-Label Study of Cycle Control With Extended Administration of Norethindrone Acetate 1 mg / Ethinyl Estradiol 20 Mcg Oral Tablets
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 207 (actual)
- Sponsor
- Warner Chilcott · Industry
- Sex
- Female
- Age
- 25 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This is an non-comparative study. There is no statistical hypothesis. The effects of extension of treatment on bleeding will be recorded and described.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Norethindrone 1 mg / ethinyl estradiol 20 mcg |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2006-06-20
- Last updated
- 2008-05-08
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00338052. Inclusion in this directory is not an endorsement.